肠内免疫营养补充ω-3多不饱和脂肪酸对重型颅脑损伤患者呼吸机治疗中呼吸机相关性肺炎并发症发生率的影响

Jinxia Liu, Xiangrong Chen, Tian-zao Huang, B. Dong, Yuxing Cai
{"title":"肠内免疫营养补充ω-3多不饱和脂肪酸对重型颅脑损伤患者呼吸机治疗中呼吸机相关性肺炎并发症发生率的影响","authors":"Jinxia Liu, Xiangrong Chen, Tian-zao Huang, B. Dong, Yuxing Cai","doi":"10.3760/CMA.J.ISSN.1674-635X.2018.05.002","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate the effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid (ω-3 PUFA) on the incidences and severity of ventilator associated pneumonia complications, inflammatory response, and the prognosis in patients with severe traumatic brain injury(sTBI)undergoing ventilator therapy. \n \n \nMethods \nFrom January 2015 to June 2017, 64 patients of sTBI were selected and randomly divided into experimental group (ω-3 PUFA, n=32) and control group(n=32). White blood cells (WBC) and the proportion of neutrophils (N%) were evaluated by cell analyzer. Meanwhile, the serum levels of C-reactive protein (CRP) and procalcitonin (PCT) were tested with enzyme linked immunosorbent assay. After 14-days treatment, the Glasgow coma scale (GCS) score, APACHE Ⅱ score, clinical pulmonary infection score (CPIS), pulmonary function and prognoses were also compared between the two groups. \n \n \nResults \nAs compared with the control group, the experimental group had lower incidences of ventilator associated pneumonia(66% vs.56%, P=0.048), reduced degree of lung infection and lower CPIS(8.25±0.60 vs.7.47±0.53); higher lung function indexes[FVC: (2.89±0.19)L vs.(3.46±0.22)L, P=0.010; FEV1: (2.35±0.16)L vs.(2.84±0.24)L, P=0.040; FEV1/FVC %: (49.11±3.34)% vs.(56.00±2.64)%, P=0.038)]; lower serum levels of inflammatory responses [WBC: (11.83±0.74)×109/L vs.(9.51±0.90)×109/L, P=0.029; N%: (79.11±1.51)% vs.(72.71±1.16)%, P=0.041; CRP: (85.15±8.42)mg/L vs.(63.96±5.72)mg/L, P=0.001; PCT: (6.43±0.47)μg/L vs.(4.83±0.39)μg/L, P=0.013]14 days after enteral immunonutrition supplemented with ω-3 PUFA. As compared with the control group, the experimental group received better prognosis with GCS scores increasing(8.69±0.41 vs.9.52±0.59, P=0.038), APACHE Ⅱ scores decreasing(14.74±1.01 vs.12.68±0.89, P=0.049), the time of mechanical ventilation [(13.23±1.17)d vs.(10.88±1.24)d, P=0.024] and the hospitalization days [(23.29±2.45)d vs.(18.42±1.96)d, P=0.012] reduced on the 14th day, mechanical ventilation withdraw rate within 14 days increasing [24/32 (75%) vs.27/32(84%), P=0.030] on the 14th day. \n \n \nConclusion \nEnteral immunonutrition supplemented with ω-3 PUFA can effectively reduce the incidence of ventilator associated pneumonia, alleviate the degree of infection and the inflammatory response in patients with sTBI undergoing ventilator therapy possibly improving condition and prognosis, which is worthy of being widely used. \n \n \nKey words: \nCraniocerebral trauma; Unsaturated fatty acid; Ventilator associated pneumonia; Inflammatory response","PeriodicalId":9877,"journal":{"name":"中华临床营养杂志","volume":"26 1","pages":"267-271"},"PeriodicalIF":0.0000,"publicationDate":"2018-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid on the incidences of ventilator associated pneumonia complications in patients with severe traumatic brain injury undergoing ventilator therapy\",\"authors\":\"Jinxia Liu, Xiangrong Chen, Tian-zao Huang, B. Dong, Yuxing Cai\",\"doi\":\"10.3760/CMA.J.ISSN.1674-635X.2018.05.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate the effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid (ω-3 PUFA) on the incidences and severity of ventilator associated pneumonia complications, inflammatory response, and the prognosis in patients with severe traumatic brain injury(sTBI)undergoing ventilator therapy. \\n \\n \\nMethods \\nFrom January 2015 to June 2017, 64 patients of sTBI were selected and randomly divided into experimental group (ω-3 PUFA, n=32) and control group(n=32). White blood cells (WBC) and the proportion of neutrophils (N%) were evaluated by cell analyzer. Meanwhile, the serum levels of C-reactive protein (CRP) and procalcitonin (PCT) were tested with enzyme linked immunosorbent assay. After 14-days treatment, the Glasgow coma scale (GCS) score, APACHE Ⅱ score, clinical pulmonary infection score (CPIS), pulmonary function and prognoses were also compared between the two groups. \\n \\n \\nResults \\nAs compared with the control group, the experimental group had lower incidences of ventilator associated pneumonia(66% vs.56%, P=0.048), reduced degree of lung infection and lower CPIS(8.25±0.60 vs.7.47±0.53); higher lung function indexes[FVC: (2.89±0.19)L vs.(3.46±0.22)L, P=0.010; FEV1: (2.35±0.16)L vs.(2.84±0.24)L, P=0.040; FEV1/FVC %: (49.11±3.34)% vs.(56.00±2.64)%, P=0.038)]; lower serum levels of inflammatory responses [WBC: (11.83±0.74)×109/L vs.(9.51±0.90)×109/L, P=0.029; N%: (79.11±1.51)% vs.(72.71±1.16)%, P=0.041; CRP: (85.15±8.42)mg/L vs.(63.96±5.72)mg/L, P=0.001; PCT: (6.43±0.47)μg/L vs.(4.83±0.39)μg/L, P=0.013]14 days after enteral immunonutrition supplemented with ω-3 PUFA. As compared with the control group, the experimental group received better prognosis with GCS scores increasing(8.69±0.41 vs.9.52±0.59, P=0.038), APACHE Ⅱ scores decreasing(14.74±1.01 vs.12.68±0.89, P=0.049), the time of mechanical ventilation [(13.23±1.17)d vs.(10.88±1.24)d, P=0.024] and the hospitalization days [(23.29±2.45)d vs.(18.42±1.96)d, P=0.012] reduced on the 14th day, mechanical ventilation withdraw rate within 14 days increasing [24/32 (75%) vs.27/32(84%), P=0.030] on the 14th day. \\n \\n \\nConclusion \\nEnteral immunonutrition supplemented with ω-3 PUFA can effectively reduce the incidence of ventilator associated pneumonia, alleviate the degree of infection and the inflammatory response in patients with sTBI undergoing ventilator therapy possibly improving condition and prognosis, which is worthy of being widely used. \\n \\n \\nKey words: \\nCraniocerebral trauma; Unsaturated fatty acid; Ventilator associated pneumonia; Inflammatory response\",\"PeriodicalId\":9877,\"journal\":{\"name\":\"中华临床营养杂志\",\"volume\":\"26 1\",\"pages\":\"267-271\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华临床营养杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2018.05.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华临床营养杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-635X.2018.05.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

摘要

目的探讨添加ω-3多不饱和脂肪酸(ω-3 PUFA)的肠内免疫营养对重型颅脑损伤(sTBI)患者呼吸机治疗中呼吸机相关肺炎并发症的发生率、严重程度、炎症反应和预后的影响。方法从2015年1月至2017年6月,选择64例sTBI患者,随机分为实验组(ω-3 PUFA,n=32)和对照组(n=32)。通过细胞分析仪评估白细胞(WBC)和中性粒细胞的比例(N%)。同时用酶联免疫吸附法测定血清C反应蛋白(CRP)和降钙素原(PCT)水平。治疗14天后,比较两组患者的格拉斯哥昏迷评分(GCS)、APACHEⅡ评分、临床肺部感染评分(CPIS)、肺功能和预后。结果与对照组相比,实验组呼吸机相关性肺炎发生率较低(66%对56%,P=0.048),肺部感染程度较低,CPIS较低(8.25±0.60对7.47±0.53);较高的肺功能指数[FVC:(2.89±0.19)L vs.(3.46±0.22)L,P=0.010;FEV1:(2.35±0.16)L vs(2.84±0.24)L;P=0.040;FEV1/FVC%:(49.11±3.34)%vs.(56.00±2.64)%,P=0.038)];在补充ω-3 PUFA的肠内免疫营养14天后,较低的炎症反应血清水平[BWBC:(11.83±0.74)×109/L vs.(9.51±0.90)×109g/L,P=0.029;N%:(79.11±1.51)%vs.(72.71±1.16)%,P=0.041;CRP:(85.15±8.42)mg/L vs.(63.96±5.72)mg/L,P=0.001;PCT:(6.43±0.47)μg/L vs.(4.83±0.39)μg/L,P=0.013]。与对照组相比,实验组预后较好,GCS评分升高(8.69±0.41 vs.9.52±0.59,P=0.038),APACHEⅡ评分降低(14.74±1.01 vs.12.68±0.89,P=0.049),机械通气时间[(13.23±1.17)d vs.(10.88±1.24)d,P=0.024],住院天数[(23.29±2.45)d vs(18.42±1.96)d,P=0.012]在第14天减少,14天内机械通气退出率增加[24/32(75%)比第14天的27/32(84%),P=0.030]。结论肠内免疫营养补充ω-3 PUFA可有效降低呼吸机相关性肺炎的发生率,减轻sTBI患者接受呼吸机治疗后的感染程度和炎症反应,改善病情和预后,值得广泛应用。关键词:颅脑损伤;不饱和脂肪酸;呼吸机相关性肺炎;炎症反应
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid on the incidences of ventilator associated pneumonia complications in patients with severe traumatic brain injury undergoing ventilator therapy
Objective To investigate the effects of enteral immunonutrition supplemented with omega-3 polyunsaturated fatty acid (ω-3 PUFA) on the incidences and severity of ventilator associated pneumonia complications, inflammatory response, and the prognosis in patients with severe traumatic brain injury(sTBI)undergoing ventilator therapy. Methods From January 2015 to June 2017, 64 patients of sTBI were selected and randomly divided into experimental group (ω-3 PUFA, n=32) and control group(n=32). White blood cells (WBC) and the proportion of neutrophils (N%) were evaluated by cell analyzer. Meanwhile, the serum levels of C-reactive protein (CRP) and procalcitonin (PCT) were tested with enzyme linked immunosorbent assay. After 14-days treatment, the Glasgow coma scale (GCS) score, APACHE Ⅱ score, clinical pulmonary infection score (CPIS), pulmonary function and prognoses were also compared between the two groups. Results As compared with the control group, the experimental group had lower incidences of ventilator associated pneumonia(66% vs.56%, P=0.048), reduced degree of lung infection and lower CPIS(8.25±0.60 vs.7.47±0.53); higher lung function indexes[FVC: (2.89±0.19)L vs.(3.46±0.22)L, P=0.010; FEV1: (2.35±0.16)L vs.(2.84±0.24)L, P=0.040; FEV1/FVC %: (49.11±3.34)% vs.(56.00±2.64)%, P=0.038)]; lower serum levels of inflammatory responses [WBC: (11.83±0.74)×109/L vs.(9.51±0.90)×109/L, P=0.029; N%: (79.11±1.51)% vs.(72.71±1.16)%, P=0.041; CRP: (85.15±8.42)mg/L vs.(63.96±5.72)mg/L, P=0.001; PCT: (6.43±0.47)μg/L vs.(4.83±0.39)μg/L, P=0.013]14 days after enteral immunonutrition supplemented with ω-3 PUFA. As compared with the control group, the experimental group received better prognosis with GCS scores increasing(8.69±0.41 vs.9.52±0.59, P=0.038), APACHE Ⅱ scores decreasing(14.74±1.01 vs.12.68±0.89, P=0.049), the time of mechanical ventilation [(13.23±1.17)d vs.(10.88±1.24)d, P=0.024] and the hospitalization days [(23.29±2.45)d vs.(18.42±1.96)d, P=0.012] reduced on the 14th day, mechanical ventilation withdraw rate within 14 days increasing [24/32 (75%) vs.27/32(84%), P=0.030] on the 14th day. Conclusion Enteral immunonutrition supplemented with ω-3 PUFA can effectively reduce the incidence of ventilator associated pneumonia, alleviate the degree of infection and the inflammatory response in patients with sTBI undergoing ventilator therapy possibly improving condition and prognosis, which is worthy of being widely used. Key words: Craniocerebral trauma; Unsaturated fatty acid; Ventilator associated pneumonia; Inflammatory response
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
中华临床营养杂志
中华临床营养杂志 Nursing-Nutrition and Dietetics
CiteScore
0.20
自引率
0.00%
发文量
2282
期刊介绍: The Chinese Journal of Clinical Nutrition was founded in 1993. It is the first professional academic journal (bimonthly) in my country co-sponsored by the Chinese Medical Association and the Chinese Academy of Medical Sciences to disseminate information on clinical nutrition support, nutrient metabolism, the impact of nutrition support on outcomes and "cost-effectiveness", as well as translational medicine and nutrition research. It is also a professional journal of the Chinese Medical Association's Parenteral and Enteral Nutrition Branch. The purpose of the Chinese Journal of Clinical Nutrition is to promote the rapid dissemination of knowledge on nutrient metabolism and the rational application of parenteral and enteral nutrition, focusing on the combination of multidisciplinary and multi-regional field investigations and clinical research. It mainly reports on nutritional risk screening related to the indications of parenteral and enteral nutrition support, "cost-effectiveness" research on nutritional drugs, consensus on clinical nutrition, guidelines, expert reviews, randomized controlled studies, cohort studies, glycoprotein and other nutrient metabolism research, systematic evaluation of clinical research, evidence-based case reports, special reviews, case reports and clinical experience exchanges, etc., and has a special column on new technologies related to the field of clinical nutrition and their clinical applications.
期刊最新文献
Trends and strategies of intestinal microecological intervention for chronic diseases Radiation induced mucositis and its relationship with nutritional status in head and neck cancer patients treated with radiotherapy Prevalence of nutritional risk and malnutrition and observation of nutritional intervention in hospitalized patients with stroke in a teaching hospital in Beijing Clinical significance of peri-operative change of serum inorganic phosphate levels after moderate-to-major abdominal surgery Clinical high-risk factors of metabolic bone disease in very low birth weight infants
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1